
Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly
New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- Hunter Syndrome ( …